Search
Filter by Topic
- (-) Remove Experiments filter Experiments
- Publications (17) Apply Publications filter
- Reproduction (12) Apply Reproduction filter
- People (5) Apply People filter
- Disorders (4) Apply Disorders filter
- Processes (4) Apply Processes filter
- Technologies (4) Apply Technologies filter
- Organisms (3) Apply Organisms filter
- Ethics (2) Apply Ethics filter
- Theories (1) Apply Theories filter
Filter by Format
- (-) Remove Articles filter Articles
Roger Sperry’s Split Brain Experiments (1959–1968)
In the 1950s and 1960s, Roger Sperry performed experiments on cats, monkeys, and humans to study functional differences between the two hemispheres of the brain in the United States. To do so he studied the corpus callosum, which is a large bundle of neurons that connects the two hemispheres of the brain. Sperry severed the corpus callosum in cats and monkeys to study the function of each side of the brain. He found that if hemispheres were not connected, they functioned independently of one another, which he called a split-brain.
Format: Articles
Subject: Experiments
The Meselson-Stahl Experiment (1957–1958), by Matthew Meselson and Franklin Stahl
In an experiment later named for them, Matthew Stanley Meselson and Franklin William Stahl in the US demonstrated during the 1950s the semi-conservative replication of DNA, such that each daughter DNA molecule contains one new daughter subunit and one subunit conserved from the parental DNA molecule. The researchers conducted the experiment at California Institute of Technology (Caltech) in Pasadena, California, from October 1957 to January 1958.
Format: Articles
Subject: Processes, Experiments
Jennifer Doudna and Emmanuelle Charpentier’s Experiment About the CRISPR/cas 9 System’s Role in Adaptive Bacterial Immunity (2012)
In 2012, Jennifer Doudna, Emmanuelle Charpentier from the University of California, Berkeley, in Berkeley, California, and Umeå University in Umeå, Sweden, along with their colleagues discovered how bacteria use the CRISPR/cas 9 system to protect themselves from viruses. The researchers also proposed the idea of using the CRISPR/cas 9 system as a genome editing tool.
Format: Articles
Subject: Experiments
The First Successful Cloning of a Gaur (2000), by Advanced Cell Technology
Advanced Cell Technology (ACT), a stem cell biotechnology company in Worcester, Massachusetts, showed the potential for cloning to contribute to conservation efforts. In 2000 ACT researchers in the United States cloned a gaur (Bos gaurus), an Asian ox with a then declining wild population. The researchers used cryopreserved gaur skin cells combined with an embryo of a domestic cow (Bos taurus). A domestic cow also served as the surrogate for the developing gaur clone.
Format: Articles
Subject: Experiments
"Genetic Control of Biochemical Reactions in Neurospora" (1941), by George W. Beadle and Edward L. Tatum
George Wells Beadle and Edward Lawrie Tatum's 1941 article Genetic Control of Biochemical Reactions in Neurospora detailed their experiments on how genes regulated chemical reactions, and how the chemical reactions in turn affected development in the organism. Beadle and Tatum experimented on Neurospora, a type of bread mold, and they concluded that mutations to genes affected the enzymes of organisms, a result that biologists later generalized to proteins, not just enzymes.
Format: Articles
Subject: Experiments
Luc Antoine Montagnier (1932-2022)
Luc Montagnier studied viruses, the immune system, and cancer in France during the second half of the twentieth century. In his early career, Montagnier studied how cancer-causing viruses replicate and infect host cells. He received the Nobel Prize in Physiology or Medicine in 2008 for his team’s discovery that a retrovirus, human immunodeficiency virus, or HIV, was the cause of acquired immunodeficiency syndrome, or AIDS. AIDS is a chronic condition that results from HIV infection and damages the immune system.
Format: Articles
Subject: People, Processes, Experiments
Management of Myelomeningocele Study Clinical Trial (2003–2010)
From February 2003 to December 2010, researchers of the Management of Myelomeningocele Study, or MOMS, clinical trial compared the safety and efficacy of different treatments for a specific type of spina bifida, called myelomeningocele. Myelomeningocele, the most frequent and severe form of spina bifida, is a condition in which the bony spinal column does not develop correctly, which causes an opening of the spine, exposure of the spinal cord, and formation of a small sac containing cerebrospinal fluid.
Format: Articles
Subject: Experiments